Showing 301 - 320 results of 102,005 for search '(( 13 points decrease ) OR ( 5 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 2.05s Refine Results
  1. 301

    Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase by Karin Simonin-Le Jeune (464354)

    Published 2013
    “…Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. …”
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308

    Decreased splicing efficiency in DENV infected cells. by Federico A. De Maio (3091644)

    Published 2016
    “…<p>(A) Schematic representation of splicing analysis. …”
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314

    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

    Published 2015
    “…For each atrial Ca<sup>2+</sup> uptake experiment, atria from four mice were pooled. n = 4 for each group. The V<sub>max</sub> of Ca<sup>2+</sup> uptake was obtained at pCa 5.5.…”
  15. 315

    Data_Sheet_5_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…We demonstrated artesunate prevented PINP in a dose-dependent manner, while exerting a clear anti-hyperalgesic effect on already existing PINP. …”
  16. 316

    Participants characteristics. by Sakiko Fukui (387048)

    Published 2025
    “…</p><p>Methods</p><p>Sixty-nine deceased older adults from five special nursing homes were studied over 3.5 years (January 2016 to June 2020). …”
  17. 317
  18. 318
  19. 319
  20. 320

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”